Immunotech Laboratories, Inc.
IMMB
Rank in Stocks
#33902
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins... Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$115.39K
Change (1 day)
0.00%
Change (1 year)
100.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Immunotech Laboratories, Inc. (IMMB)
Category
Healthcare
Operating Margin for Immunotech Laboratories, Inc. (IMMB)
Operating Margin as of November 2026 TTM: 0.00%
According to Immunotech Laboratories, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2016 the company had an operating margin of 0.00%.
Operating Margin history for Immunotech Laboratories, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | -100.00% |
| 2003 | -2,770.75% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Immunotech Laboratories, Inc.'s operating margin
What was Immunotech Laboratories, Inc.'s operating margin in 2016?
In 2016, Immunotech Laboratories, Inc.'s operating margin was 0.00%, compared with 0.00% in 2013.
How has Immunotech Laboratories, Inc.'s operating margin changed since 2013?
From 2013 to 2016, Immunotech Laboratories, Inc.'s operating margin was highest in 2016 (0.00%) and lowest in 2016 (0.00%).
How does Immunotech Laboratories, Inc.'s operating margin compare with similar companies?
Immunotech Laboratories, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.